Medication interactions can pose a significant health risk. Identifying and understanding the degree of interaction and appropriate management allows for optimization of care while minimizing risk. In this interview, Glenn A. Hirsch, Barbara Wiggins, and Henry D. Huang discuss drug-drug interactions of concern in contemporary cardiovascular care.

post
Source

https://www.acc.org/latest-in-cardiology/articles/2020/11/23/18/46/accel-lite-2020nov24

Tags

Therapeutic Modality ,Pharmacotherapeutics,TPHT_others